Skip to content

Memory Problems Perceptions Among Patients and Accompaniers During Diagnosis Process :

Study of Memory Problems Perceptions With the French Adaptation of the Illness Perception Questionnaire Memory, Among Patients Who Come for the First Time at a Memory Center Until Diagnosis Disclosure Post-visit

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02299154
Acronym
REMAD
Enrollment
250
Registered
2014-11-24
Start date
2014-12-31
Completion date
2017-11-30
Last updated
2016-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Memory Disorders, Alzheimer Disease

Brief summary

This study aims to prospectively examine the memory problem perceptions of patients with memory complaints \[MCs\] and their accompaniers during the diagnostic process.

Detailed description

Through the french adaptation of the illness perception questionnaire memory, this study aims to prospectively examine the memory problem perceptions of patients with memory complaints \[MCs\] and their accompaniers during the diagnostic process. The investigators plan to recruit 125 patients with MCs who come for the first time at the Research and Resources Memory Center in Nancy, France. Participants have to express MCs and must be free of dementia diagnosis at the first visit. Participants also need to be accompanied by an accompanier and both have to be fluent in French. This study has been approved by our local Ethics Committee (Committee for the Protection of Persons) and the French Health Security Agency. After giving their informed consent, patients and accompaniers are followed up throughout the diagnostic process with three visits : at their first visit, at one month after the first visit, and at six months after the diagnosis disclosure.

Interventions

Psychological questionnaires about memory problems perceptions, anxiety, depression, quality of life and coping

Sponsors

France Alzheimer
CollaboratorOTHER
Laboratoire APEMAC :Maladies chroniques, santé perçue, processus d adaptation, France
CollaboratorUNKNOWN
Central Hospital, Nancy, France
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

For patients with memory complaints: * Age over 18 years * Have a memory complaints with a QPC score greater than or equal to 3 * Be accompanied by a next of kin * Folstein MMSE greater than or equal to 15/30 * Have given their written consent after receiving clear and intelligible oral and written information * Social security coverage For Accompaniers : * Age over 18 years * Consent to participate at the study with the patient * Have given their written consent after receiving clear and intelligible oral and written information * Social security coverage * Be in contact with the patient at least 8 hours per week. It could be physical contact or telephone contact.

Exclusion criteria

For patients with memory complaints: * Sensory deficit interfering with the completion of the questionnaires * Level of French insufficient to complete the questionnaires * Legally protected person * Diagnosis of neurocognitive disorders already established * Treatment for Alzheimer Disease * Refusal or inability to obtain written informed consent form from the patient * Included in another experimental study at inclusion visit For Accompaniers: * Sensory deficit interfering with the completion of the questionnaires * Level of French insufficient to complete the questionnaires * Refusal or inability to obtain written informed consent form from the accompanier

Design outcomes

Primary

MeasureTime frameDescription
Memory problems perceptions of patients and next of kin during diagnosis processBaseline and 6 months after diagnosis disclosureHow patients and accompaniers perceive memory problems at the first visit in a Memory Center to 6 months after the diagnosis disclosure, with the Illness Perception Questionnaire Memory

Secondary

MeasureTime frameDescription
Psychometric properties of the french adaptation of the Ilness Perceptions Questionnaire - Memory (IPQ-M, Hurt et al. 2010)Baseline, 1 month later and 6 months after diagnosis disclosurePsychometric properties of IPQ-M by a traditional approach and by comparison to another french memory complaint questionnaire
Impact of the memory problems perceptions on mood and well-beingBaseline and 6 months after diagnosis disclosureCorrelation between memory problems perceptions at the IPQ-M, levels of anxiety (STAI-Y), depression (MADRS), quality of life (WHOQOL-BREF) and coping strategies.
Differences of memory problems perceptions and coping according to level of cognitive disorder at the Mini-Mental State Examination (MMSE)Baseline and 6 months after diagnosis disclosure

Countries

France

Contacts

Primary Contactchristine perret-guillaume, PhD, MD
c.perret-guillaume@chu-nancy.fr+33383153322
Backup Contactanaick besozzi, M's D
a.besozzi@chu-nancy.fr+33383157099

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026